+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Cancer Monoclonal Antibodies Market Size, Share and Growth Outlook, 2026: Analysis By Antibody Type (Humanized Monoclonal Antibodies, Human Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Murine Monoclonal Antibodies), By Application (Blood Cancer , Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Liver Cancer), By End-User (Hospitals, Research Institutes, Specialty Oncology Centers, Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Cancer Monoclonal Antibodies Market size is forecast to increase from $112.1 Billion in 2026 to $444.77 Billion in 2034 at a CAGR of 18.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006147
Pages: 216 Pages

Cancer Immunotherapy Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors , Cancer Vaccines, Immunomodulators , Cell-Based Therapies , Oncolytic Virus Therapies), By Cancer Type (Lung Cancer, Breast Cancer, Melanoma and Skin Cancers, Prostate Cancer, Hematologic Malignancies , Colorectal and Gastrointestinal Cancers), By Route of Administration (Intravenous , Subcutaneous or Intratumoral Injection, Oral Administration), By End-User (Hospitals and Multi-Specialty Clinics, Academic and Cancer Research Centers, Ambulatory and Specialty Infusion Centers), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacy Distributors, Retail and Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Cancer Immunotherapy Market size is forecast to increase from $187.46 Billion in 2026 to $447.82 Billion in 2034 at a CAGR of 11.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006146
Pages: 224 Pages

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Target Identification and Validation, Lead Screening and Characterization, Cell-Based Assays and Immune Profiling, Biomarker Validation and Assay Development), By Drug Type Focus (Monoclonal Antibodies , Immunomodulators , Oncolytic Viral Therapies and Cancer Vaccines, Adoptive Cell Therapies ), By Cancer Type Focus (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Ovarian and Pancreatic Cancer), By Client (Pharmaceutical Corporations, Biotechnology Firms, Academic and Dedicated Cancer Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cancer Immunotherapy Drug Discovery Outsourcing Market size is forecast to increase from $1.86 Billion in 2026 to $3.82 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006145
Pages: 218 Pages

Cancer Gene Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Modality (Gene-Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer , CRISPR-Based Gene-Editing Therapies, RNAi-Based Gene-Silencing Therapies), By Vector Type (Viral Vectors , Non-Viral Vectors ), By Cancer Type (Hematologic Malignancies , Solid Tumors ), By Manufacturing Source (In-House Facilities, Contract Development & Manufacturing Organizations ), By End-User (Hospitals and Specialized Cancer Centers, Biotechnology and Pharmaceutical Companies, Academic and Government Research Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Cancer Gene Therapy Market size is forecast to increase from $8 Billion in 2026 to $28.48 Billion in 2034 at a CAGR of 17.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006144
Pages: 213 Pages

Cancer Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Product (Consumables, Instruments), By Test Type (Tumor Biomarker Tests, Imaging Tests, Biopsy Tests), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Blood Cancers), By End-User (Hospitals, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cancer Diagnostics Market size is forecast to increase from $130.31 Billion in 2026 to $212.44 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006143
Pages: 212 Pages

Cancer Diagnostic Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product (Pathology-based Instruments, Imaging Instruments, Biopsy Instruments), By Technology (Polymerase Chain Reaction , Next-generation Sequencing , Immunohistochemistry , In Situ Hybridization , Microarrays, Flow Cytometry, Immunoassays), By End-User (Hospitals, Diagnostic Centers, Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cancer Diagnostic Devices Market size is forecast to increase from $36.64 Billion in 2026 to $59.73 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006142
Pages: 212 Pages

Cancer Cachexia Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Therapeutic Class (Ghrelin Receptor Agonists, Selective Androgen Receptor Modulators , Beta-blockers , Progestogens, Corticosteroids, Combination Therapy), By Mechanism of Action (Appetite Stimulators, Anabolic Agents, Catabolic-Pathway Inhibitors, Anti-inflammatory , Weight Loss Stabilizers), By Cancer Type (Lung Cancer, Gastro-intestinal Cancers, Breast Cancer, Prostate Cancer, Hematologic Malignancies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Cancer Cachexia Therapeutics Market size is forecast to increase from $2.82 Billion in 2026 to $4.01 Billion in 2034 at a CAGR of 4.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006141
Pages: 210 Pages

Cancer Cachexia Market Size, Share and Growth Outlook, 2026: Analysis By Product (Progestogens, Corticosteroids, Combination Therapies, Anabolic Steroids & SARMs, Nutritional Supplements & Medical Foods), By Mechanism of Action (Appetite Stimulants, Myostatin Inhibitors, Ghrelin Receptor Agonists, Anti-inflammatory Agents), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Cancer Treatment Centers, Hospitals, Homecare Settings, Palliative Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global Cancer Cachexia Market size is forecast to increase from $2.6 Billion in 2026 to $3.53 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006140
Pages: 226 Pages

Cancer Biopsy Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Instruments , Kits and Consumables, Needle-based Devices , Software & Bioinformatics), By Procedure (Tissue Biopsy , Liquid Biopsy , Others ), By Application (Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Skin Cancer), By End-User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers , Cancer Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cancer Biopsy Market size is forecast to increase from $40.57 Billion in 2026 to $78.5 Billion in 2034 at a CAGR of 8.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006139
Pages: 218 Pages

Cancer Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Biomarker Type (Genetic Biomarkers , Protein Biomarkers , Epigenetic Biomarkers, Metabolomic Biomarkers), By Profiling Technology (Omics Technologies , Imaging Technologies , Immunoassays , Bioinformatics & Cytogenetics), By Application (Diagnostics , Research and Development , Prognostics, Risk Assessment, Personalized Medicine), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Leukemia & Lymphoma), By End-User (Diagnostic Laboratories, Biopharmaceutical Companies, Academic & Research Institutes, Hospitals & Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Cancer Biomarkers Market size is forecast to increase from $38.77 Billion in 2026 to $93.28 Billion in 2034 at a CAGR of 11.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006138
Pages: 221 Pages